Aimei Health Technology Co., Ltd (NASDAQ:AFJK - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,900 shares, an increase of 35.7% from the December 31st total of 1,400 shares. Approximately 0.0% of the company's shares are sold short. Based on an average trading volume of 54,000 shares, the days-to-cover ratio is currently 0.0 days.
Aimei Health Technology Price Performance
Shares of NASDAQ:AFJK traded up $0.01 during mid-day trading on Thursday, reaching $10.68. 1,493 shares of the company's stock were exchanged, compared to its average volume of 69,320. Aimei Health Technology has a twelve month low of $10.15 and a twelve month high of $10.85. The business's fifty day moving average price is $10.67 and its 200-day moving average price is $10.54.
Institutional Investors Weigh In On Aimei Health Technology
Several institutional investors and hedge funds have recently made changes to their positions in AFJK. Rivernorth Capital Management LLC boosted its holdings in Aimei Health Technology by 9.1% in the third quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company's stock valued at $1,811,000 after acquiring an additional 14,391 shares during the last quarter. Virtu Financial LLC bought a new stake in Aimei Health Technology in the third quarter worth approximately $123,000. Glazer Capital LLC lifted its stake in Aimei Health Technology by 3.4% in the third quarter. Glazer Capital LLC now owns 608,670 shares of the company's stock valued at $6,379,000 after buying an additional 19,896 shares during the period. Mizuho Securities USA LLC grew its position in shares of Aimei Health Technology by 60.7% during the 3rd quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company's stock worth $4,627,000 after buying an additional 167,223 shares during the period. Finally, Wolverine Asset Management LLC increased its stake in shares of Aimei Health Technology by 8.6% in the 3rd quarter. Wolverine Asset Management LLC now owns 539,039 shares of the company's stock valued at $5,649,000 after acquiring an additional 42,843 shares in the last quarter. Institutional investors and hedge funds own 45.58% of the company's stock.
Aimei Health Technology Company Profile
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Recommended Stories
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
